Exelixis Inc. buy BiotechBee
Start price
08.09.24
/
80%
€23.18
Target price
31.12.26
€30.00
Performance (%)
45.56%
End price
14.12.24
€33.74
Summary
This prediction ended on 14.12.24 with a price of €33.74. With a performance of 45.56% the BUY prediction by BiotechBee was a big success. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | -0.368% | -0.368% | 27.808% |
| iShares Core DAX® | 0.855% | 1.375% | 2.609% |
| iShares Nasdaq 100 | -0.989% | -3.844% | 25.552% |
| iShares Nikkei 225® | -1.781% | -8.530% | 42.813% |
| iShares S&P 500 | 0.057% | 0.610% | 21.574% |
According to BiotechBee what are the pros and cons of Exelixis Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Exelixis Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Exelixis Inc.
Buy beendet

